http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103328433-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
filingDate 2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a336f17084c1ad62ab0cfd5c02188144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21111d75639b46dc1f45fc81fe7d8f4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5611e02979ef458c24e6b1ba72f8acf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c5bc93afbfd2f8643a2e3dcef9c1c50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5137f8b569c13f02f753e1d34814b3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad298ecc4d7b13d08d34606a6b96d119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0244989be905d60764af91d1cc776208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164d703f8d8d42a2d2f2d137c10cbbf6
publicationDate 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103328433-A
titleOfInvention Analgesic compounds, methods and formulations
abstract Analgesic compounds of formula I and salts thereof are provided: wherein A is (A). In addition, pharmaceutical formulations and methods of use using the above-mentioned compounds are provided .
priorityDate 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3652589-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03048113-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2022778-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467252388

Total number of triples: 34.